Related Experiment Video

Updated: Oct 20, 2025

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.0K

Non-Coding RNAs in Stem Cell Regulation and Cardiac Regeneration: Current Problems and Future Perspectives

Victor Schweiger1, Ena Hasimbegovic1, Nina Kastner1

  • 1Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

International Journal of Molecular Sciences
|September 10, 2021
PubMed

Insights

Non-coding RNAs, like circular RNAs and microRNAs, show promise for cardiac regeneration by regulating stem cells. These molecules offer a potential solution to heart damage after myocardial infarction when stem cell therapy faces challenges.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Molecular Biology

Background:

  • Acute myocardial infarction (AMI) leads to cardiomyocyte loss and impaired ventricular function, often resulting in heart failure.
  • The heart's poor regenerative capacity necessitates novel therapeutic strategies for myocardial repair.
  • Current stem cell therapies for cardiac repair face challenges like poor retention and oncogenic risks.

Purpose of the Study:

  • To review the role of non-coding RNAs (ncRNAs) in regulating stem cells for cardiac regeneration.
  • To explore the potential of circular RNAs (circRNAs) and microRNAs (miRNAs) in activating resident cells or stem cells for myocardial repair.
  • To discuss the advantages of ncRNAs as regulators of stem cells and drivers of cardiac regeneration.

Main Methods:

  • Literature review focusing on ncRNAs, stem cell regulation, and cardiac regeneration.
  • Analysis of studies investigating circRNAs and miRNAs in the context of myocardial repair.
  • Synthesis of findings on the therapeutic potential of ncRNAs in cardiovascular disease.

Main Results:

  • ncRNAs, including circRNAs and miRNAs, play crucial roles in cell proliferation and differentiation.
  • These ncRNAs can regulate stem cell activity and potentially induce stem cell status in resident cells.
  • ncRNAs offer an alternative strategy to direct stem cell delivery for cardiac repair.

Conclusions:

  • ncRNAs represent a promising avenue for cardiac regeneration, addressing limitations of traditional stem cell therapies.
  • circRNAs and miRNAs are key regulators with significant potential for stimulating myocardial repair and improving ventricular function post-AMI.
  • Further research into ncRNA-based therapies could lead to effective treatments for heart failure following myocardial infarction.

Keywords:
circRNAdifferentiationmiRNAstem cells

More Related Videos

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues13:03

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues

Published on: June 3, 2016

8.3K
Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.6K

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.4K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.6K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K